| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.002 | 0.9 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |